2Adams WA, Mark - senior J, Jones RS, et al. cis - Atrac urium in dogs with and without polo- systemic shunt[ J]. Vel An- aestl Analg,2006,33 ( 1 ): 17.
3Ahuja TS, Freeman D, Mahnken JD, et al. Predictor of the development of hyperkalemia in patients uling angiotensin conver- ting enzyme inhibitors[J]. Am J. Nephrol,2000, 20(2) :268.
4Bryson HM, Faulds D. Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice [J]. Drugs,1997,53(5) : 848.
5Imbeault K,Withinqton DE, Varin F. Pharmacokinetics and pharmacodynamics of a 0. 1 mg/kg dose of cisatracurium besylate in children during N2O/O2/propofol anesthesia [ J ] . Anesth Analg,2006,102 (3) : 738.
6Donlon JV Jr, Savarese JJ, Ali HH, et al. Human dose - re- sponse curves for neuromuscular blocking drugs: a comparison of two methods of construction and analysis [ J ] . Anesthesiology, 1980,53(2) : 161.
8Selcuk M, Celebioglu B, Celiker V,et al. Infusion and bolus administration of cisatracurium effects on histamine release [J]. Middle East J Anesthesiol,2005,18 (2) : 407.
1O'Hara DA,Fragen RJ,Shanks CA.The effects of age on the dose-response curves for vecuronium in adults.Anesthesiology,1985,63:542-544.
2D'Hollander AA,Massaux F,Nevelsteen M,et al.Age dependent dose-response relationship of Org NC45 in anaesthetized patients.Br J Anaesth,1982,54:653-656.
3Rupp SM,Castagnoli KP,Fisher DM,et al.Pancuronium and vecuronium pharmacokinetics and pharmacodynamics in younger and elderly adults.Anesthesiology,1987,67:45-49.
4Rupp SM,Fisher DM,Miller RD,et al.Pharmacokinetics and pharmacodynamics of vecuronium in the elderly.Anesthesiology,1983,59:A270.
5Lien C,Matteo R,Ornstein E,et al.Distribution,elimination,and action of vecuronium in the elderly.Anesth Analg,1991,73:39-42.
6Boyd AH,Eastwood NB,Parker CJR,et al.Pharmacodynamics of the 1R cis-1'R Cis isomer of Atracurium(51W89)in Health and Renal Failure.Anesth,1995,74:400-404.
7Sztark F,Cantini O,Bourdalle-Badie C,et al.Continuous infusion of cisatracurium in patients with renal dysfunction.Anesthesiology,1999,91:A1037.
8Ahuja TS,Freeman D,Mahnken JD,et al.Predictor of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors.Am J Nephrol,2000,20:268-272.
9Bakris GL,Weir WR.Angiotensin-converting enzyme inhibitor associated elevations in serum creatinine is this cause for concern? Arch Intern Med,2000,160:685-693.
10Gregor M,Singer I,Willian J,et al.Prevalence of ACE-inhibitor use in diabetic hypertensives in hypertension speciality clinic:a guality assurance review.Am J Cardio,2002.15,215-219.
6Hruza M,Schulze M,Teber D,et al.Laparoscopic techniques for removal of renal and ureteral calculi[J].Journal of Endourology,2009;23( 10): 1713- 1718.
7Pieters BJ,Penn E,Nicklaus P, et al.Emergence delirium and postoperative pain in children undergoing adenotonsillectomy:a comnparison of propofol vs sevoflurane anesthesia[J ].Pediatric Anesthesia,2010;20( 10):944-950.
8Mencke T, Schreiber JU, Becket C, et al. Pretreatment before succinyl-choline for outpatient anesthesia [ J ] .9 Anesth Analg, 2002, 94:573 - 576.
9Ahuja T S,Freeman D Jr,Mahnken J D,et al. Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors [J].Am J Nephrol,2002,20 (4) : 268-272.
